Peter Marks Resigns From Position At FDA

By
Rachel Stevenson
-

Well, well, well—look who finally got shown the door at the FDA. Dr. Peter Marks, the guy who’s been practically stapled to Big Pharma’s hip for the last several years, was just given the classic Washington D.C. send-off: resign or get fired. And honestly, it’s about time. The man who oversaw vaccine approvals, cell therapies, gene treatments—and, more notably, the increasingly politicized rollout of the COVID vaccine—has finally exited stage left. Cue the smallest violin.

Marks made headlines (and not the good kind) for pushing COVID vaccines on young children, despite a gaping lack of solid data showing any measurable benefit for that age group. But hey, why let something like “evidence” get in the way when you’ve got a pharmaceutical PR tour to keep up with, right?

This is the same official who bypassed internal FDA staff evaluations not once, not twice, but three times to greenlight a multiple sclerosis drug that had already flunked clinical trials. He also swooped in to approve a lab-grown blood vessel treatment with mixed safety data. Because nothing says “science-based regulation” like ignoring scientists.

Let’s be real: Marks wasn’t running the FDA like a watchdog; he was running it like a concierge desk for biotech investors. His vision of “public health” had a suspiciously cozy alignment with pharmaceutical profit margins, and when someone like RFK Jr. came in with ideas that didn’t revolve around rubber-stamping new drugs at warp speed, the clash was inevitable.

Now, Robert F. Kennedy Jr.—yes, that Kennedy—is in the mix, and unlike the usual D.C. careerist, he’s coming in with a sledgehammer. He’s planning to launch a vaccine injury division within the CDC, and the timing couldn’t be more telling. For years, Americans were told to “trust the science,” but the science often looked more like political theater—backed by rushed studies, suppressed data, and an army of bureaucrats like Marks insisting they knew best.

But the kicker? Marks, on his way out, tried to paint himself as a martyr. In a farewell letter dripping with sanctimony, he accused Secretary Kennedy of not caring about the truth, of spreading lies, and of wanting “subservient confirmation” instead of transparency. Really, Peter? You, the guy who overrode internal experts multiple times, are now waving the transparency flag? That’s rich.

He even warned that Kennedy was “undermining confidence” in “well-established vaccines.” Which sounds noble, until you remember the FDA’s standards have been anything but gold lately. Fast-tracked approvals, conflict-of-interest-laden advisory boards, and zero accountability for adverse outcomes don’t exactly inspire confidence. And if questioning that shaky foundation is dangerous, then maybe it’s the foundation that needs inspection, not the people asking questions.

Let’s also not forget what’s at stake here. Kennedy’s vaccine injury agency isn’t some abstract idea. It’s a direct challenge to the legacy of people like Marks, who pushed aggressive vaccine schedules, often with minimal long-term safety data and zero recourse for those harmed. If Kennedy succeeds—and let’s face it, a lot of Americans are rooting for him—it could mean actual accountability.

We’re talking investigations, hearings, and yes, possibly criminal charges if violations of the Nuremberg Code come into play. You know, that pesky little set of international ethical guidelines designed to prevent medical experimentation on humans without consent.

So let’s call this what it is: the end of an era where unelected bureaucrats operated behind closed doors with little scrutiny and even less humility. And as for Marks, if he’s truly the hero he’s making himself out to be, then history will vindicate him. But if he’s been shielding bad science, silencing dissent, and pushing meds for the benefit of stockholders instead of patients? Then he’s not just retiring—he’s escaping.

Good riddance.

RELATED ARTICLESMORE FROM AUTHOR